Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5685322 | American Journal of Kidney Diseases | 2017 | 13 Pages |
Abstract
Evidence for induction therapy for lupus nephritis is inconclusive based on treatment effects on all-cause mortality, doubling of serum creatinine level, and end-stage kidney disease. MMF, calcineurin inhibitors, or their combination were most effective for inducing remission compared to IV cyclophosphamide, while conferring similar or lower treatment toxicity. MMF was the most effective maintenance therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Suetonia C. MBChB, PhD, David J. MIPH, Davinder MBBS, PhD, Dimitris PhD, Marcello MD, David W. MBBS (Hons), PhD, Jonathan C. MBChB, PhD, Allison PhD, Giovanni F.M. MD, PhD,